ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716260 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716260; 2) Community: the network communities that were significantly associated with the response to NSC 716260; 3) Molecule: the relationships between components within communities and NSC 716260; 4) MDR: the compounds that were significantly associated with the NSC 716260.

NSC Compound Enrichment Correlation
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.043472147060915 0.18872936
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.043472147060915 0.19003981
NSC 715407 Null 0.043472147060915 0.50779939
NSC 718630 Null 0.0434721470609156 0.13020274
NSC 718781 Erlotinib hydrochloride 0.0434721470609156 -0.084434611
NSC 720495 Null 0.0434721470609156 0.17163604
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0434721470609156 0.2282893
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0434721470609156 0.20951157
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0434721470609156 0.16715799
NSC 743532 Null 0.0434721470609156 0.33389347
Total:142  Current:115    [First] [Prev] [Next] [Last]